Cargando…
Characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody
Adipsic hypernatremia is a rare disease presenting as persistent hypernatremia with disturbance of thirst regulation and hypothalamic dysfunction. As a result of congenital disease, tumors, or inflammation, most cases are accompanied by structural abnormalities in the hypothalamic-pituitary area. Wh...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627220/ https://www.ncbi.nlm.nih.gov/pubmed/29026268 http://dx.doi.org/10.1297/cpe.26.197 |
_version_ | 1783268673104904192 |
---|---|
author | Nakamura-Utsunomiya, Akari Hiyama, Takeshi Y. Okada, Satoshi Noda, Masaharu Kobayashi, Masao |
author_facet | Nakamura-Utsunomiya, Akari Hiyama, Takeshi Y. Okada, Satoshi Noda, Masaharu Kobayashi, Masao |
author_sort | Nakamura-Utsunomiya, Akari |
collection | PubMed |
description | Adipsic hypernatremia is a rare disease presenting as persistent hypernatremia with disturbance of thirst regulation and hypothalamic dysfunction. As a result of congenital disease, tumors, or inflammation, most cases are accompanied by structural abnormalities in the hypothalamic-pituitary area. While cases with no hypothalamic-pituitary structural lesion have been reported, their etiology has not been elucidated. Recently, we reported three patients with adipsic hypernatremia whose serum-derived immunoglobulin (Ig) specifically reacted with mouse subfornical organ (SFO) tissue. As one of the circumventricular organs (CVOs) that form a sensory interface between the blood and brain, the SFO is a critical site for generating physiological responses to dehydration and hypernatremia. Intravenous injection of the patient’s Ig fraction induced hypernatremia in mice, along with inflammation and apoptosis in the SFO. These results support a new autoimmunity-related mechanism for inducing adipsic hypernatremia without demonstrable hypothalamic-pituitary structural lesions. In this review, we aim to highlight the characteristic clinical features of these patients, in addition to etiological mechanisms related to SFO function. These findings may be useful for diagnosing adipsic hypernatremia caused by an autoimmune response to the SFO, and support development of new strategies for prevention and treatment. |
format | Online Article Text |
id | pubmed-5627220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Japanese Society for Pediatric Endocrinology |
record_format | MEDLINE/PubMed |
spelling | pubmed-56272202017-10-12 Characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody Nakamura-Utsunomiya, Akari Hiyama, Takeshi Y. Okada, Satoshi Noda, Masaharu Kobayashi, Masao Clin Pediatr Endocrinol Review Adipsic hypernatremia is a rare disease presenting as persistent hypernatremia with disturbance of thirst regulation and hypothalamic dysfunction. As a result of congenital disease, tumors, or inflammation, most cases are accompanied by structural abnormalities in the hypothalamic-pituitary area. While cases with no hypothalamic-pituitary structural lesion have been reported, their etiology has not been elucidated. Recently, we reported three patients with adipsic hypernatremia whose serum-derived immunoglobulin (Ig) specifically reacted with mouse subfornical organ (SFO) tissue. As one of the circumventricular organs (CVOs) that form a sensory interface between the blood and brain, the SFO is a critical site for generating physiological responses to dehydration and hypernatremia. Intravenous injection of the patient’s Ig fraction induced hypernatremia in mice, along with inflammation and apoptosis in the SFO. These results support a new autoimmunity-related mechanism for inducing adipsic hypernatremia without demonstrable hypothalamic-pituitary structural lesions. In this review, we aim to highlight the characteristic clinical features of these patients, in addition to etiological mechanisms related to SFO function. These findings may be useful for diagnosing adipsic hypernatremia caused by an autoimmune response to the SFO, and support development of new strategies for prevention and treatment. The Japanese Society for Pediatric Endocrinology 2017-09-28 2017 /pmc/articles/PMC5627220/ /pubmed/29026268 http://dx.doi.org/10.1297/cpe.26.197 Text en ©2017 The Japanese Society for Pediatric Endocrinology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Nakamura-Utsunomiya, Akari Hiyama, Takeshi Y. Okada, Satoshi Noda, Masaharu Kobayashi, Masao Characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody |
title | Characteristic clinical features of adipsic hypernatremia patients with
subfornical organ-targeting antibody |
title_full | Characteristic clinical features of adipsic hypernatremia patients with
subfornical organ-targeting antibody |
title_fullStr | Characteristic clinical features of adipsic hypernatremia patients with
subfornical organ-targeting antibody |
title_full_unstemmed | Characteristic clinical features of adipsic hypernatremia patients with
subfornical organ-targeting antibody |
title_short | Characteristic clinical features of adipsic hypernatremia patients with
subfornical organ-targeting antibody |
title_sort | characteristic clinical features of adipsic hypernatremia patients with
subfornical organ-targeting antibody |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627220/ https://www.ncbi.nlm.nih.gov/pubmed/29026268 http://dx.doi.org/10.1297/cpe.26.197 |
work_keys_str_mv | AT nakamurautsunomiyaakari characteristicclinicalfeaturesofadipsichypernatremiapatientswithsubfornicalorgantargetingantibody AT hiyamatakeshiy characteristicclinicalfeaturesofadipsichypernatremiapatientswithsubfornicalorgantargetingantibody AT okadasatoshi characteristicclinicalfeaturesofadipsichypernatremiapatientswithsubfornicalorgantargetingantibody AT nodamasaharu characteristicclinicalfeaturesofadipsichypernatremiapatientswithsubfornicalorgantargetingantibody AT kobayashimasao characteristicclinicalfeaturesofadipsichypernatremiapatientswithsubfornicalorgantargetingantibody |